Literature DB >> 19011675

Cardiovascular and airway relaxant activities of peony root extract.

Muhammad N Ghayur1, Anwarul H Gilani, Huma Rasheed, Abdullah Khan, Zafar Iqbal, Muhammad Ismail, Sheikh A Saeed, Luke J Janssen.   

Abstract

Paeonia emodi (peony) is a well known plant used medicinally to treat hypertension, palpitations, and asthma. Despite its popularity, there are few reports in the scientific literature examining its use in such conditions. We prepared a 70% ethanolic extract of peony root (Pe.Cr) and applied it to segments of guinea pig atria and trachea and rat aorta suspended separately in tissue baths. Activity against arachidonic acid (AA)-induced platelet aggregation was measured in human platelet-rich plasma. Airway relaxant effect was evaluated against acetylcholine (ACh)-induced airway contraction in mouse lung slices loaded with fluo-4. Pe.Cr (0.3-10 mg/mL) showed an atropine-resistant negative inotropic effect in atria. In rat aorta, an endothelium-independent vasodilatory effect (0.3-10 mg/mL) was seen in phenylephrine- and high-K+-induced contractions. Pe.Cr (0.01-1 mg/mL) also inhibited AA-induced platelet aggregation. In isolated trachea, Pe.Cr (0.3-10 mg/mL) relaxed carbachol- and histamine-induced contractions independently of beta-adrenergic receptors. In mouse lung slices, Pe.Cr (0.3-1 mg/mL) inhibited ACh-induced airway narrowing and oscillations of intracellular Ca2+ in airway smooth muscle cells. The results showed cardiosuppressant, vasodilatory, antiplatelet, and tracheal and airway relaxant activities of peony, providing potential justification for its medicinal use in different hyperactive cardiovascular and respiratory disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19011675     DOI: 10.1139/Y08-084

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  4 in total

1.  A natural way to cardiovascular health.

Authors:  Muhammad N Ghayur; Luke J Janssen
Journal:  Nat Rev Cardiol       Date:  2010-03       Impact factor: 32.419

Review 2.  Exploring lung physiology in health and disease with lung slices.

Authors:  Michael J Sanderson
Journal:  Pulm Pharmacol Ther       Date:  2011-05-12       Impact factor: 3.410

3.  Tongxinluo inhibits neointimal formation by regulating the expression and post-translational modification of KLF5 in macrophages.

Authors:  Wen Jiang; Bin Zheng; Xin-Hua Zhang; Ling-Yan Yue; Chan Liu; Dong Ma; Zhan Yang; Jin-Kun Wen
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

Review 4.  Current Advances in the Use of Nanophytomedicine Therapies for Human Cardiovascular Diseases.

Authors:  Mahvash Hesari; Pantea Mohammadi; Fatemeh Khademi; Dareuosh Shackebaei; Saeideh Momtaz; Narges Moasefi; Mohammad Hosein Farzaei; Mohammad Abdollahi
Journal:  Int J Nanomedicine       Date:  2021-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.